SS 12 - Sarcoma 1: From Margins to Mainstream: Advances in our Understanding of Rare Bone, Cutaneous, and Connective Tissue Tumors

Presentations

• 04:45pm - 04:55pm PT

  Sacral Chordoma: A Randomized and Observational Study on Surgery vs. Definitive Radiotherapy in Primary Localized Disease (SACRO)

  Speaker: Piero Fossati, MD - MedAustron Ion therapy Center, Weiner Neustadt
• 04:55pm - 05:05pm PT

  The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma Microsatellitosis

  Speaker: Kelsey Nordlund, BS - MD Anderson Cancer Center, Houston
• 05:05pm - 05:15pm PT

  A Prospective Single-Arm Trial of Postoperative 36 Gy in 10 Fractions for Merkel Cell Carcinoma

  Speaker: Devarati Mitra, MD, PhD - University of Texas MD Anderson Cancer Center, Houston
• 05:15pm - 05:25pm PT

  Long-Term Failure Patterns and Prognostic Factors in a Randomized Dose-Escalation Trial for Skull Base Chordomas: A Secondary Analysis from PROG 85-26

  Speaker: Myrsini Ioakeim-Ioannidou, MD - Massachusetts General Hospital, Boston
• 05:25pm - 05:35pm PT

  Surgical Graft and Flap Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma

  Speaker: Noel Yang, BS - MD Anderson Cancer Center, Houston
• 05:35pm - 05:45pm PT

  Does Dose Avoidance of Uninvolved Skin/Subcutaneous Tissues Reduce Morbidity in Preoperative Intensity-Modulated Radiation Therapy for Soft Tissue Sarcomas of the Lower Extremity?

  Speaker: Siyer Roohani, MD - Princess Margaret Cancer Center, University Health Network, Toronto